![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 15
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 15
Showing 15 citing articles:
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
Fanchong Jian, Jing Wang, Ayijiang Yisimayi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 16
Fanchong Jian, Jing Wang, Ayijiang Yisimayi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 16
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines
Ida Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Open Access | Times Cited: 7
Ida Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Open Access | Times Cited: 7
A generalized framework to identify SARS-CoV-2 broadly neutralizing antibodies
Fanchong Jian, Anna Z. Wec, Leilei Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Fanchong Jian, Anna Z. Wec, Leilei Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Rethinking Optimal Immunogens to Face SARS‐CoV‐2 Evolution Through Vaccination
Julià Blanco, Benjamin Trinité, Joan Puig‐Barberà
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
Julià Blanco, Benjamin Trinité, Joan Puig‐Barberà
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-COV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
(2024)
Open Access | Times Cited: 5
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
(2024)
Open Access | Times Cited: 5
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 900-900
Open Access | Times Cited: 4
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 900-900
Open Access | Times Cited: 4
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses
Ida Paciello, Giulio Pierleoni, Elisa Pantano, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114645-114645
Open Access | Times Cited: 2
Ida Paciello, Giulio Pierleoni, Elisa Pantano, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114645-114645
Open Access | Times Cited: 2
Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Zuowei Wang, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Zuowei Wang, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants
Mengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
EBioMedicine (2024) Vol. 108, pp. 105354-105354
Open Access | Times Cited: 1
Mengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
EBioMedicine (2024) Vol. 108, pp. 105354-105354
Open Access | Times Cited: 1
Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Zuowei Wang, Ling Li, Ruiping Du, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111557-111557
Open Access | Times Cited: 1
Zuowei Wang, Ling Li, Ruiping Du, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111557-111557
Open Access | Times Cited: 1
Longitudinal profiling of B cells primed by mRNA vaccine and recalled by Omicron variants uncovers antibodies broadly neutralizing sarbecoviruses
Xixian Chen, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xixian Chen, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent
Yuanyuan Hu, Caiqin Hu, Shuo Wang, et al.
Pathogens (2024) Vol. 13, Iss. 4, pp. 272-272
Open Access
Yuanyuan Hu, Caiqin Hu, Shuo Wang, et al.
Pathogens (2024) Vol. 13, Iss. 4, pp. 272-272
Open Access
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case
Takeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
EBioMedicine (2024) Vol. 110, pp. 105439-105439
Closed Access
Takeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
EBioMedicine (2024) Vol. 110, pp. 105439-105439
Closed Access
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access
Emi E. Nakayama, Tatsuo Shioda
Pathogens (2024) Vol. 13, Iss. 12, pp. 1109-1109
Open Access